Article Details
Retrieved on: 2019-03-24 15:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>Shanghai-based Abbisko Therapeutics has closed a $42-million Series B funding round led by venture capital firm <b>Qiming Venture Partners</b>.</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here